Does FERROUS GLYCINE Cause Hyperparathyroidism secondary? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hyperparathyroidism secondary have been filed in association with FERROUS GLYCINE. This represents 11.2% of all adverse event reports for FERROUS GLYCINE.
25
Reports of Hyperparathyroidism secondary with FERROUS GLYCINE
11.2%
of all FERROUS GLYCINE reports
0
Deaths
25
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From FERROUS GLYCINE?
Of the 25 reports, 25 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FERROUS GLYCINE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does FERROUS GLYCINE Cause?
Bradycardia (48)
Atrial fibrillation (47)
General physical health deterioration (45)
Overdose (44)
Dizziness (40)
Hypertension (40)
Spinal stenosis (37)
Nausea (35)
Oedema peripheral (35)
Chronic kidney disease (34)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which FERROUS GLYCINE Alternatives Have Lower Hyperparathyroidism secondary Risk?
FERROUS GLYCINE vs FERROUS\FERROUS, DRIED
FERROUS GLYCINE vs FERROUS\FOLIC ACID
FERROUS GLYCINE vs FERUMOXYTOL
FERROUS GLYCINE vs FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
FERROUS GLYCINE vs FESOTERODINE